NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor

Karen J. Fritchie, Long Jin, Brian P. Rubin, Peter C. Burger, Sarah M. Jenkins, Sarah Barthelmeb, Evgeny A. Moskalev, Florian Haller, Andre M. Oliveira, Caterina Giannini

Research output: Contribution to journalArticle

Abstract

Meningeal solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are considered to be distinct entities in the WHO Classification of CNS Tumours (2007). They harbor NAB2-STAT6 fusions similar to their soft tissue counterparts, supporting the view that they are part of a tumor continuum. We examined 30 meningealbased tumors originally diagnosed as either SFT or HPC. These showed a spectrum of morphologic features and were diagnosed as SFTs, malignant SFTs, HPCs, or tumors with "intermediate" features. All of the tumors showed nuclear expression of STAT6. SFTs consistently expressed diffuse CD34, while HPCs and intermediate tumors had heterogeneous staining. NAB2-STAT6 fusions were identified in 20 cases, including 7 with exon 4-exon 3, 9 with exon 6-exon 17, and 4 with exon 6-exon 18 fusions. NAB2 exon 4-STAT6 exon 3 fusion correlated with classic SFT morphology and older age and showed a trend toward less mitotic activity; there was also a trend toward more aggressive behavior in tumors lacking NAB2 exon 4-STAT6 exon 3. Thus, despite their clinical and morphologic differences, meningeal-based SFTs, HPCs, and tumors with intermediate features, similar to their soft tissue counterparts, form a histopathologic spectrum unified by STAT6 immunoexpression and NAB2-STAT6 fusion.

Original languageEnglish (US)
Pages (from-to)263-271
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume75
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Solitary Fibrous Tumors
Hemangiopericytoma
Gene Fusion
Exons
Neoplasms
Meningeal Neoplasms

Keywords

  • Meningeal hemangiopericytoma
  • Meningeal solitary fibrous tumor
  • NAB2-STAT6
  • STAT6

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Fritchie, K. J., Jin, L., Rubin, B. P., Burger, P. C., Jenkins, S. M., Barthelmeb, S., ... Giannini, C. (2016). NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor. Journal of Neuropathology and Experimental Neurology, 75(3), 263-271. https://doi.org/10.1093/jnen/nlv026

NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor. / Fritchie, Karen J.; Jin, Long; Rubin, Brian P.; Burger, Peter C.; Jenkins, Sarah M.; Barthelmeb, Sarah; Moskalev, Evgeny A.; Haller, Florian; Oliveira, Andre M.; Giannini, Caterina.

In: Journal of Neuropathology and Experimental Neurology, Vol. 75, No. 3, 2016, p. 263-271.

Research output: Contribution to journalArticle

Fritchie, KJ, Jin, L, Rubin, BP, Burger, PC, Jenkins, SM, Barthelmeb, S, Moskalev, EA, Haller, F, Oliveira, AM & Giannini, C 2016, 'NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor', Journal of Neuropathology and Experimental Neurology, vol. 75, no. 3, pp. 263-271. https://doi.org/10.1093/jnen/nlv026
Fritchie, Karen J. ; Jin, Long ; Rubin, Brian P. ; Burger, Peter C. ; Jenkins, Sarah M. ; Barthelmeb, Sarah ; Moskalev, Evgeny A. ; Haller, Florian ; Oliveira, Andre M. ; Giannini, Caterina. / NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor. In: Journal of Neuropathology and Experimental Neurology. 2016 ; Vol. 75, No. 3. pp. 263-271.
@article{94e9bbbc416e46b7b5664cbab695c4e6,
title = "NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor",
abstract = "Meningeal solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are considered to be distinct entities in the WHO Classification of CNS Tumours (2007). They harbor NAB2-STAT6 fusions similar to their soft tissue counterparts, supporting the view that they are part of a tumor continuum. We examined 30 meningealbased tumors originally diagnosed as either SFT or HPC. These showed a spectrum of morphologic features and were diagnosed as SFTs, malignant SFTs, HPCs, or tumors with {"}intermediate{"} features. All of the tumors showed nuclear expression of STAT6. SFTs consistently expressed diffuse CD34, while HPCs and intermediate tumors had heterogeneous staining. NAB2-STAT6 fusions were identified in 20 cases, including 7 with exon 4-exon 3, 9 with exon 6-exon 17, and 4 with exon 6-exon 18 fusions. NAB2 exon 4-STAT6 exon 3 fusion correlated with classic SFT morphology and older age and showed a trend toward less mitotic activity; there was also a trend toward more aggressive behavior in tumors lacking NAB2 exon 4-STAT6 exon 3. Thus, despite their clinical and morphologic differences, meningeal-based SFTs, HPCs, and tumors with intermediate features, similar to their soft tissue counterparts, form a histopathologic spectrum unified by STAT6 immunoexpression and NAB2-STAT6 fusion.",
keywords = "Meningeal hemangiopericytoma, Meningeal solitary fibrous tumor, NAB2-STAT6, STAT6",
author = "Fritchie, {Karen J.} and Long Jin and Rubin, {Brian P.} and Burger, {Peter C.} and Jenkins, {Sarah M.} and Sarah Barthelmeb and Moskalev, {Evgeny A.} and Florian Haller and Oliveira, {Andre M.} and Caterina Giannini",
year = "2016",
doi = "10.1093/jnen/nlv026",
language = "English (US)",
volume = "75",
pages = "263--271",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor

AU - Fritchie, Karen J.

AU - Jin, Long

AU - Rubin, Brian P.

AU - Burger, Peter C.

AU - Jenkins, Sarah M.

AU - Barthelmeb, Sarah

AU - Moskalev, Evgeny A.

AU - Haller, Florian

AU - Oliveira, Andre M.

AU - Giannini, Caterina

PY - 2016

Y1 - 2016

N2 - Meningeal solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are considered to be distinct entities in the WHO Classification of CNS Tumours (2007). They harbor NAB2-STAT6 fusions similar to their soft tissue counterparts, supporting the view that they are part of a tumor continuum. We examined 30 meningealbased tumors originally diagnosed as either SFT or HPC. These showed a spectrum of morphologic features and were diagnosed as SFTs, malignant SFTs, HPCs, or tumors with "intermediate" features. All of the tumors showed nuclear expression of STAT6. SFTs consistently expressed diffuse CD34, while HPCs and intermediate tumors had heterogeneous staining. NAB2-STAT6 fusions were identified in 20 cases, including 7 with exon 4-exon 3, 9 with exon 6-exon 17, and 4 with exon 6-exon 18 fusions. NAB2 exon 4-STAT6 exon 3 fusion correlated with classic SFT morphology and older age and showed a trend toward less mitotic activity; there was also a trend toward more aggressive behavior in tumors lacking NAB2 exon 4-STAT6 exon 3. Thus, despite their clinical and morphologic differences, meningeal-based SFTs, HPCs, and tumors with intermediate features, similar to their soft tissue counterparts, form a histopathologic spectrum unified by STAT6 immunoexpression and NAB2-STAT6 fusion.

AB - Meningeal solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) are considered to be distinct entities in the WHO Classification of CNS Tumours (2007). They harbor NAB2-STAT6 fusions similar to their soft tissue counterparts, supporting the view that they are part of a tumor continuum. We examined 30 meningealbased tumors originally diagnosed as either SFT or HPC. These showed a spectrum of morphologic features and were diagnosed as SFTs, malignant SFTs, HPCs, or tumors with "intermediate" features. All of the tumors showed nuclear expression of STAT6. SFTs consistently expressed diffuse CD34, while HPCs and intermediate tumors had heterogeneous staining. NAB2-STAT6 fusions were identified in 20 cases, including 7 with exon 4-exon 3, 9 with exon 6-exon 17, and 4 with exon 6-exon 18 fusions. NAB2 exon 4-STAT6 exon 3 fusion correlated with classic SFT morphology and older age and showed a trend toward less mitotic activity; there was also a trend toward more aggressive behavior in tumors lacking NAB2 exon 4-STAT6 exon 3. Thus, despite their clinical and morphologic differences, meningeal-based SFTs, HPCs, and tumors with intermediate features, similar to their soft tissue counterparts, form a histopathologic spectrum unified by STAT6 immunoexpression and NAB2-STAT6 fusion.

KW - Meningeal hemangiopericytoma

KW - Meningeal solitary fibrous tumor

KW - NAB2-STAT6

KW - STAT6

UR - http://www.scopus.com/inward/record.url?scp=84962449536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962449536&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlv026

DO - 10.1093/jnen/nlv026

M3 - Article

C2 - 26883114

AN - SCOPUS:84962449536

VL - 75

SP - 263

EP - 271

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 3

ER -